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The type III secretion systems (TTSS) encoded in Salmonella pathogenicity island-1 and -2 (SPI-1 and -2) are virulence
factors required for specific phases of Salmonella infection in animal hosts. However, the host cell types targeted by
the TTSS have not been determined. To investigate this, we have constructed translational fusions between the ß-
lactamase reporter and a broad array of TTSS effectors secreted via SPI-1, SPI-2, or both. Secretion of the fusion protein
to a host cell was determined by cleavage of a specific fluorescent substrate. In cultured cells, secretion of all six
effectors could be observed. However, two to four days following i.p. infection of mice, only effectors secreted by SPI-2
were detected in spleen cells. The cells targeted were identified via staining with nine different cell surface markers
followed by FACS analysis as well as by conventional cytological methods. The targeted cells include B and T
lymphocytes, neutrophils, monocytes, and dendritic cells, but not mature macrophages. To further investigate
replication in these various cell types, Salmonella derivatives were constructed that express a red fluorescent protein.
Bacteria could be seen in each of the cell types above; however, most viable bacteria were present in neutrophils. We
find that Salmonella is capable of targeting most phagocytic and non-phagocytic cells in the spleen but has a
surprisingly high preference for neutrophils. These findings suggest that Salmonella specifically target splenic
neutrophils presumably to attenuate their microbicidal functions, thereby promoting intracellular survival and
replication in the mouse.
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Introduction
The innate and adaptive immune systems of the host
present a formidable barrier to infection. To overcome the
multi-faceted defenses, microbial pathogens have evolved
equally complex mechanisms that are only partially under-
stood. One of these mechanisms is the type III secretion
system (TTSS) found in many Gram-negative bacterial
pathogens. These are sophisticated secretion devices that
inject speciﬁc proteins (called effectors) directly into the host
cell cytoplasm. Various cell culture models are used to study
effectors but the cell types targeted by the Salmonella TTSS
during the course of infection have not been studied.
Salmonella enterica serovar Typhimurium (referred to as S.
typhimurium hereafter) has two TTSSs that are expressed
under different conditions and required for distinct aspects
of infection [1–3]. Effectors secreted by the Salmonella
pathogenicity island-1 TTSS (SPI-1 TTSS) are associated with
the invasion of intestinal epithelial cells and enhanced
intestinal inﬂammation in infected hosts [4–6]. The Salmonella
pathogenicity island-2 TTSS (SPI-2 TTSS) is required for
intracellular survival during the systemic phase of infection
[7–11], but it also enhances inﬂammation during the enteric
phase [12,13]. In previous work, effectors could be placed into
three categories; those secreted via SPI-1 TTSS only, those
secreted by SPI-2 TTSS only, or those secreted by both
[14,15]. Additional roles for SPI-1 and SPI-2 are still being
found. For example, Lawley et al. found that components of
the SPI-1 TTSS are required for persistence in a chronic
infection model in 129X1/SvJ mice [16].
Whether Salmonella persists or kills its host is determined by
several factors such as the route of administration, the strain
of Salmonella, and the strain of mouse infected. Acute
infection is usually studied in Balb/c or C57BL/6 mice because
they are as sensitive to S. typhimurium infection as humans are
to S. enterica serovar Typhi. In acute mouse infection
Salmonella moves rapidly to the two ﬁltering organs, the
spleen and liver, and within those organs is found in
macrophages, neutrophils, and dendritic cells [17–22]. Macro-
phages are considered the primary reservoir of Salmonella
because survival within macrophages is an essential virulence
mechanism [23]. However, the speciﬁc cell types targeted by
SPI-1 TTSS and SPI-2 TTSS in vivo have not been identiﬁed.
In this study, mice were infected i.p. with strains of S.
typhimurium expressing different effector-ß-lactamase (Bla)
fusions. This reporter system allows detection of secreted
effectors by detecting cleavage of coumarin cephalosporin
ﬂuorescein (CCF2-AM) [24,25]. This dye is cell permeant but
is rapidly cleaved by endogenous cytoplasmic esterases
resulting in a charge moiety that is concentrated within the
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ﬂuorescence resonance energy transfer (FRET) altering the
emission spectrum from green to blue. Three-laser FACS
analysis allowed us to simultaneously identify multiple cell
surface markers and CCF2-AM ﬂuorescence thus identifying
targeted cells more accurately than was possible in a previous
study with Yersinia [26]. Our results show that only the SPI-2
TTSS is active in the mouse spleen and that many cell types
are infected with viable bacteria.
Results
Effector-Bla Fusions Are Secreted into Cultured Cells
Six effector proteins were selected because they display
different secretion patterns in cultured cell lines and are
directly involved in virulence [4,15,16,27–30]. These secreted
proteins were classiﬁed into three groups based on their
secretion patterns in cultured cells [15]: SPI-1 only, SPI-2
only, and SPI-1/2. The ﬁrst group, referred to as S1, includes
two proteins, both encoded within Salmonella pathogenicity
island 1: SipA and SptP (although SptP is secreted at low
levels through SPI-2 TTSS). The second group, S2, consists of
SteC and SseJ. The last group, S1/2, includes SteA and SlrP
secreted via both SPI-1 and SPI-2 TTSS.
We generated chromosomally encoded effector-Bla fusions
in S. typhimurium strain 14028 to the six TTSS effectors listed
above and tested them to verify the appropriate secretion
patterns in cultured cells. Translational fusions to each of
these effectors were expressed from their natural location on
the chromosome in order to maintain their native expression
patterns. In addition, each fusion was tested to ensure that
the derivative retained virulence. For initial experiments, we
used cultured cells and infection conditions under which only
SPI-1 or SPI-2 TTSS was expressed. The six Bla fusion strains
were tested for secretion following infection of HeLa cells for
2 hours and the J774 macrophage-like cell line for 10 hours
using either SPI-1 or SPI-2 TTSS inducing conditions,
respectively. We found that the expression of the Bla fusions
had no effect on the course of infection in these cells lines
and that intracellular bacteria were present at all time points
investigated. Following the infection, the cells were loaded
with CCF2-AM (Invitrogen). Under SPI-1 TTSS inducing
conditions, microscopic analysis revealed blue cells among
the HeLa cells infected with the S1 and S1/2 fusion strains
indicating CCF2-AM cleavage by Bla (Figure 1A). No blue
cells were observed in HeLa cells infected with the S2 fusions
or in control infections with 14028 or 14028 harboring
pWKS30, a plasmid expressing wild-type ß-lactamase protein
that is not secreted via TTSS [31]. When SPI-1-dependent
infection of HeLa cells was extended to 8 and 20 hours,
secretion of S2 effectors was detected (Figure 1D), indicating
that the SPI-2 TTSS is active within epithelial cells at these
times. Using SPI-2 inducing conditions, blue cells could be
seen in J774s infected with the S1/2 and S2 Bla fusions (Figure
1B). A low level of secretion was observed in J774s infected
with the SptP-Bla strain. No blue cells were observed in J774s
infected with SipA-Bla or control infections. No secretion was
observed from strains in which the secretion apparatus had
been inactivated (Figure 1C). These results conﬁrmed that
secretion by the six Bla fusion strains could be detected in
cultured cells under the appropriate infection conditions.
Detection of Secretion Was Optimal 2 Days following
Infection
To test secretion in an in vivo model, C57BL/6 mice were
inoculated via i.p. infection with S. typhimurium strains
expressing the effector-Bla fusions. Spleens from infected
mice were then removed at 24-hour intervals, homogenized,
and loaded with CCF2-AM. FACS analysis was performed to
detect CCF2-AM cleavage. We were only able to detect
secretion in mice when the bacterial load in the spleen was
greater than ;3 3 10
7 and therefore could not detect
secretion within the ﬁrst 24 hours of infection. If the bacterial
load exceeded 1 3 10
8, the mice became septic resulting in
overt splenic cell death making the analysis questionable.
Despite this narrow window we could reproducibly recover
between 3 3 10
7 and 1 3 10
8 bacteria from the spleen 2 days
following infection (Figure S1A) and therefore performed all
studies using these conditions. By counting viable bacteria
recovered from the spleen of infected mice, we conﬁrmed
that none of the effector-Bla fusion strains exhibited any
defect in their ability to colonize and replicate within the
spleen. It is unclear why no secretion could be detected at 24
hours post-infection.
Red Fluorescent Bacteria Detected within Secretion-
Positive ‘‘Blue’’ Cells
To determine if cells staining blue with CCF2 also contain
live Salmonella we expressed Tomato red ﬂuorescent protein
in each Bla-fusion derivative [32]. Tomato is a red ﬂuorescent
protein that has an emission spectrum that does not overlap
the other ﬂuorescent dyes used in this work. Splenic cells
were scanned by eye for those that ﬂuoresce blue and then
examined for the presence of red bacteria (Figure 2). Only
cells expressing Bla-fusions to SteA, SlrP, SteC, and SseJ gave
positive results. Furthermore, every blue cell identiﬁed also
contained red-ﬂuorescent bacteria (.100 cells). 3-D recon-
struction conﬁrmed that the bacteria associated with these
cells were intracellular (Video S1).
Secretion of S2 Effector-Bla Fusions Was Detected in
Splenocytes by FACS
At 48, 72, and 96 hours post i.p. infection of Salmonella,
varying degrees of secretion could be detected by FACS
analysis. However, due to the fact that many mice were dead
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Author Summary
Bacteria of the Salmonella genus are important human pathogens
and a leading cause of food-borne illness. Salmonella species’ ability
to cause disease relies on the activities of two sophisticated
molecular syringes that allow the bacteria to pump proteins into
cells that they infect. The activities of these syringes have been
studied extensively in cells grown under laboratory conditions and
shown to be essential for the infectious process in animal models.
However, the specific cells within infected organs that are targeted
by these syringes have not been identified. In this work we describe
the specific spleen cells targeted by Salmonella in the mouse. We
find that Salmonella is capable of targeting most cell types using
their molecular syringes. Quite surprisingly, we find that Salmonella
mostly targets neutrophils, a cell type not thought to be associated
with live Salmonella in host tissues. These findings challenge our
current views of Salmonella infection and may lead to new insight
for treating the disease.72 or 96 hours post inoculation, we performed the majority
of our analysis after 48 hours. Secretion was detected only in
mice infected with strains harboring S1/2 and S2 effector
fusions (SteA, SlrP, SteC and SseJ; Figure 3A and 3B). No
secretion was detected in mice infected with SipA and SptP
effector (S1) fusions. Therefore, the in vivo secretion we
observed is likely due to the expression of the SPI-2 TTSS.
This ﬁnding corresponds well with the virulence data,
indicating that SPI-2 but not SPI-1 TTSS is required for
spleen colonization and morbidity in this acute mouse
infection model (Figure S1B and S1C, Protocol S1). In this
same FACS analysis it was not possible to detect internalized
bacteria expressing Tomato because the appropriate excita-
tion wavelength was not available. However, bacteria could be
detected microscopically following cell sorting of blue
ﬂuorescent cells (see below).
Identification of Spleen Cells Containing ß-Lactamase
Reporter Fusions
To identify the cell types that were targeted by S.
typhimurium, spleen cells were loaded with CCF2-AM, then
stained with several ﬂuorescently conjugated antibodies and
Figure 1. Visualization of Secretion in HeLa Cells (A) and J774s (B) by Microscopy (603 Magnification)
S. typhimurium 14028 strains expressing Bla fusions to SipA, SptP, SlrP, SteA, SteC, and SseJ; WT 14028, or 14028 harboring pWKS30 were used to infect
HeLa cells for 2 hours using SPI-1-inducing conditions and J774s for 10 hours using SPI-2- inducing conditions. Following the infections, cells were
loaded with CCF2-AM and visualized for green and blue fluorescence by microscopy. Green fluorescence indicates CCF2-AM was loaded and the
presence of blue cells is evidence of secretion. SPI-1 TTSS- and SPI-2 TTSS-dependent secretion detected by FACS analysis (C). HeLa cells and J774s were
infected as described above with the six effector-Bla fusions that were expressed in WT 14028, invA::cat and ssaK::cat backgrounds, mutations in
structural components of SPI-1 and SPI-2 TTSS, respectively. FACS analysis was performed on CCF2-AM loaded cells to determine the percentage of blue
cells (positive for secretion). Background percentage of blue cells was set using WT 14028–infected cells. At least 10,000 cells were analyzed for each
sample. Each bar represents the mean percentage of blue cells from triplicate samples and the error bars are 6 one standard error of the mean. FACS
analysis was also performed on HeLa cells infected with each Bla fusion strain for 1, 8, or 20 hours using SPI-1 inducing conditions (D).
doi:10.1371/journal.ppat.0030196.g001
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Targets of Salmonella Type III Secretionanalyzed by FACS. Beta-lactamase fusions to SipA or SptP
were not analyzed because secretion of these effectors could
not be detected in splenic cells (Figure 3). Using FACS
analysis, we were able to simultaneously detect four cell-
surface markers, as well as blue and green CCF2-AM
ﬂuorescence. Each sample was split into two groups and
stained with a total of eight ﬂuorescent antibodies. One
group was stained with antibodies that recognize cell surface
markers speciﬁc for T cells and B cells (CD4, CD8, CD3, and
CD19) and the second group was stained with antibodies to
distinguish macrophages, neutrophils, monocytes and den-
dritic cells (CD11b, CD11c, GR-1, and F4/80). Parallel samples
were stained with propidium iodide to stain dead cells and
determine their light scattering properties enabling exclusion
of . 90% of dead cells from our analysis. Dead cells do not
load with CCF2-AM because retention of this dye requires
active cell processes ([25]; Figure S2). Therefore the contri-
bution of autoﬂuorescence from dead cells was minimized.
Table 1 summarizes the percentage of each spleen cell type
that was observed in infected and uninfected mice as well as
the marker designations used to deﬁne each cell type. The
percentage of lymphocytes, mature macrophages, monocytes
and neutrophils in infected mice, as determined by FACS,
corresponded well with the percentages observed by analyz-
ing Wright-Giemsa stained slides. Monocytes found in tissues
are considered macrophages. However, we distinguish mature
macrophages from monocytes by the presence of tingible
bodies on Wright-Giemsa stains as well as by the presence of
cell surface markers. Monocytes express intermediate to high
levels of both GR-1 and CD11b on their surface whereas
mature macrophages do not (our unpublished observation;
[33–35]). Table 2 shows the percentage of blue spleen cells
represented by speciﬁc cell types from mice infected with
effector-Bla fusion expressing Salmonella strains. There was no
statistically signiﬁcant difference in the cell types targeted by
each effector. Secretion could be detected in all cell
populations analyzed including CD4 T cells, CD8 T cells, B
cells, dendritic cells, monocytes and neutrophils but not
mature macrophages. Most of the secretion (;73% of blue
cells) was found in GR-1þ/CD11bþ monocytes and neutro-
phils. Thus, there were several surprising results that
warranted additional investigation.
The absence of mature macrophages as targets of type III
secretion was puzzling hence we carried out additional
controls to verify this conclusion. Spleen cell suspensions
were infected with the effector-Bla fusion strains in vitro for
1 hour using SPI-1 TTSS inducing conditions, loaded with
CCF2-AM and analyzed by FACS. This control conﬁrmed
CCF2-AM cleavage could be detected in all cell types
including mature macrophages (Figure S3).
The GR-1þ/CD11bþCell Population Consists of Monocytes
and Neutrophils
Wright-Giemsa staining of FACS sorted GR-1þ/CD11bþ
cells from infected mice revealed that these cells consist of
neutrophils (;80%) and monocytes (;20%) (Figure 4A and
4C). GR-1þ/CD11bþ cells were further subdivided into two
distinct populations based on the levels of GR-1 and CD11c
staining. Wright-Giemsa staining of FACS sorted cells from
infected mice demonstrated that GR-1 Int/CD11c Hi cells
were mostly monocytes (.72%) and GR-1 Hi/CD11c Lo cells
were mostly neutrophils (.90%) (Figure 4C). GR-1 Int/CD11c
Hi cells (mostly monocytes) represent ;18% of the secretion
positive cells while the GR-1 Hi/CD11c Lo cells (mostly
neutrophils) represent the greatest percentage of the targeted
cells (;55% of blue cells) (Table 2).
These results differ somewhat from previous work based on
distinguishing infected cell types with F4/80 [18]. We found
that F4/80 is expressed on most GR-1þ/CD11bþ cells regard-
less of CD11c expression during infection (Figure 4B). This
indicates that F4/80 cannot distinguish splenic monocytes
from neutrophils. However, in uninfected mice, the majority
of the spleen cells expressing F4/80 are indeed monocytes and
macrophages (Table 1 and Figure 4A). CD115 is also used to
distinguish monocytes in uninfected animals. However
following infection we detected CD115 on both neutrophils
and monocytes (Figure S4). Therefore it appears that
infection itself alters the expression pattern of many cell
surface proteins including those that are most often used to
distinguish monocytes, macrophages and neutrophils.
GR-1þ/CD11bþ Cells Contain Viable Bacteria
The GR-1þ/CD11bþ splenic neutrophils and monocytes
increased dramatically following infection (Table 1, Figure
4A). These are inﬁltrating professional phagocytic cells that
play a crucial role in innate immunity by directly killing the
invading microbe. We wished to determine whether secretion
to these cells correlated with the presence of viable intra-
cellular bacteria or whether the cleaved CCF2-AM was by
residual ß-lactamase, left over after the Salmonella bacteria
were killed. GR-1þ/CD11bþcells were FACS sorted, lysed, and
plated on LB agar to determine the number of CFU present
as compared to the number of CFU from total splenic cells.
GR-1þ/CD11bþ cells consistently contained most of the total
Figure 2. Microscopic Analysis of a Blue Spleen Cell Containing
Intracellular Salmonella
Mice were infected i.p. for 48 hours with 14028 expressing a
chromosomal SteA-Bla construct and harboring pWKS30-Tomato, a red
fluorescent protein expression vector (shown in red). Spleen cell
suspensions were prepared then loaded with CCF2-AM (blue) to detect
secretion and a DNA stain, DRAQ5 (green), to visualize nuclei. The image
was taken at 603 magnification.
doi:10.1371/journal.ppat.0030196.g002
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Targets of Salmonella Type III Secretionintracellular CFU recovered from the spleen of infected mice
(Figure 4D, ;90% on average). Separation of the cells into
neutrophils and monocytes revealed that ;70% of the
intracellular CFUs were associated with neutrophil enriched
population while ;20% were associated with a monocyte-
enriched population. Thus, in spite of the fact that
neutrophils are very microbicidal, most bacteria were isolated
from these cells. We also wished to distinguish between
Salmonella actively growing within cells versus simply not yet
killed. One way to do this is to examine the cells in which
cleavage of CCF2 has taken place for the presence of multiple
intact bacteria, as described in the next section.
FACS Sorted Blue Cells Contain Intracellular Salmonella
To determine if cells in which CCF2 had been cleaved
contained intracellular bacteria we simultaneously expressed
SteA-Bla and Tomato ﬂuorescent protein in the same
Salmonella derivative. Following infection of C57BL/6 mice,
splenic cells were treated with CCF2, and blue ﬂuorescent
cells were isolated via FACS sorting. We conﬁrmed by Wright-
Giemsa staining that the blue cells were mostly neutrophils
and that the remaining cells were a mixture of monocytes and
lymphocytes. A fraction of the sorted cells were examined for
the presence of intracellular bacteria by ﬂuorescence micro-
scopy. In addition, samples were stained with the nuclear
stain, DRAQ5 to aid in distinguishing cell type. Every
Figure 3. Detection of Secretion in C57BL/6 Spleen Cells
FACS data with levels of green and blue CCF2-AM fluorescence in spleen cells from mice infected with each fusion strain (A). Green fluorescence
indicates CCF2-AM is present within the cells. The percentage of blue cells, positive for secretion, is shown in the lower right corner of each dot plot. The
graph below shows the percentage of total spleen cells emitting blue fluorescence as detected by FACS analysis (B). Each X represents the value for one
mouse infected with the indicated strain and horizontal bars represent the average value of seven mice. The * denotes samples for which the Student’s
t-test returned a value where p , 0.05 when compared to 14028-infected mice.
doi:10.1371/journal.ppat.0030196.g003
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Targets of Salmonella Type III Secretionsecretion positive cell that we visualized contained red-
ﬂuorescent bacteria that appeared to be intact (Figure 5 and
supplemental videos). Most of these cells had nuclei with a
multi-lobed appearance suggesting that they were neutro-
phils (see Videos S2–S5 for visualization of nuclei). Nearly all
neutrophils contained multiple bacteria most likely resulting
from intracellular replication. The number of infected cells
was always ,2% of total splenocytes. The low ratio of
bacteria to phagocytes indicates a low probability that the
same cell could encounter multiple bacteria. Therefore it is
u n l i k e l yt h a tt h ep r e s e n c eo fm u l t i p l eb a c t e r i aw i t h i n
neutrophils resulted from sequential phagocytic events. Thus,
the data suggests that Salmonella is replicating within GR-1þ/
CD11bþ neutrophils.
Salmonella Internalization by B and T Cells Is SPI-1
Independent
In tissue culture experiments, SPI-1 TTSS is required for
cell invasion in non-professional phagocytic cells. We there-
fore wished to determine if SPI-1 TTSS were required for
internalization by B and T cells and whether SPI-2 TTSS
dependent secretion in these cells is associated with intra-
cellular Salmonella. To test if uptake by B and T cells occurred
via SPI-1 mediated cell invasion the same FACS analysis as
above was repeated but in a strain containing a mutation in
the SPI-1 structural apparatus (invA::cat). Mice were infected
with this strain or the wild-type control containing both
SteA-Bla and Tomato ﬂuorescent protein. Two days after
infection cells expressing ß-lactamase and CD19þ (B cells) or
CD3þ (T cells) were sorted, stained with DRAQ5, and
analyzed by ﬂuorescence microscopy. As expected, sorted
cells had nuclear morphology typical of lymphocytes. These
cells contained red-ﬂuorescent bacteria for both the SPI-1
mutation and the control (Figure 6). FACS analysis also
revealed that secretion into T and B cells occurred at the
same frequency in the absence of invA (Table S1). These
results indicate that Salmonella infects non-phagocytic T and B
cells in a SPI-1 TTSS independent manner.
Discussion
This is the ﬁrst report detailing the cell types targeted by
Salmonella’s TTSS during a course of infection. Within the
spleen a variety of cell types including neutrophils, mono-
cytes, and B and T lymphocytes all showed ß-lactamase
cleavage of CCF2-AM demonstrating secretion. Not only were
the cells targeted by type III secretion but intact bacteria
were also observed in each of these cells. The presence of
viable replicating bacteria within monocytes is expected but
the presence within neutrophils suggests that Salmonella must
be defending itself successfully against microbicidal factors
present in these cells.
Salmonella encodes two different type III secretion systems
that play distinct roles by secreting different virulence factors
at speciﬁc steps during infection. In this work six different
secreted effectors were chosen because their secretion
patterns were diverse. Two were secreted by SPI-1 TTSS,
two secreted by SPI-2 TTSS and two secreted by either
apparatus. Although SPI-1 plays a role in a chronic mouse
Table 1. FACS Analysis of Spleen Cells from Uninfected and
Infected Mice
Cell Type Cell-Surface Markers % Spleen Cells
b
Uninfected Infected
CD4 T cells CD4þ/CD3þ 19.1 6 2.3 14.7 6 0.8
CD8 T cells CD8þ/CD3þ 8.7 6 2.2 7.9 6 0.5
B cells CD19þ/CD3- 35.9 6 3.7 40.5 6 1.4
DCs
a CD11cþ 3.4 6 0.5 3.8 6 0.3
Macrophages
a CD11c  and CD11bþ and/or F4/80þ 2.1 6 0.7 1.3 6 0.2
GR-1þ/CD11bþ GR-1þ/CD11bþ 2.0 6 0.5 7.6 6 0.6
Monocytes
c CD11bþ/GR-1 Int /CD11c Hi 0.18 6 0.1 1.5 6 0.1
Neutrophils
c CD11bþ/GR-1 Hi /CD11c Lo 1.8 6 0.4 6.1 6 0.5
aGR-1þ/CD11bþ double positive cells (cells falling in the R1 gate in Figure 4A) were
excluded from these populations.
bValues shown are averages of at least five mice 6 one standard error of the mean.
cMonocytes and neutrophils are subsets of GR-1þ/CD11bþ cells.
doi:10.1371/journal.ppat.0030196.t001
Table 2. Percentage of Blue Spleen Cells Represented by Specific Cell Types from Mice Infected with Effector-Bla Fusion Expressing
Salmonella Strains
Cell Type % of Blue Cells Represented by Specific Cell Types
a
Salmonella Strain
SlrP-Bla SteA-Bla SteC-Bla SseJ-Bla Total
b
CD4 T cells 4.6 5.6 6.4 7.1 6.6 6 0.4
CD8 T cells 6.5 7.8 5.8 6.4 7.6 6 0.7
B cells 9.8 10.3 6.5 9.9 9.1 6 0.9
DCs 1.8 1.2 2.6 2.6 2.1 6 0.3
Macrophages ND
c ND
c ND
c ND
c ND
c
GR-1þ/CD11bþ 76 73.9 71.8 71.4 73.2 6 1.1
Monocytes
d 15.1 18.2 20.3 19.7 18.3 6 1.2
Neutrophils
d 60.9 55.7 51.5 51.5 54.9 6 2.2
aThe infections were performed as in described in the text and the values represent the average percentages of blue cells that were of each cell type from at least three mice.
bThe Total column is the average value of the four different fusions 6 one standard error of the mean.
cND, not detected.
dMonocytes and neutrophils are subsets of GR-1þ/CD11bþ cells.
doi:10.1371/journal.ppat.0030196.t002
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Targets of Salmonella Type III Secretioninfection [16] it had no effect in our acute infection model.
Only SPI-2 TTSS dependent secretion was observed in the
mouse spleen after 48 hours of infection. However, we cannot
rule out the possibility that SPI-1 TTSS–dependent secretion
occurs below our limits of detection, at later time points of
infection, in different organs, or into the extracellular space.
In a recent report the cell types targeted by Yersinia type III
secretion were examined with ﬁndings that differed from
those reported here. These investigators found variations in
the cellular targets for secretion of different effectors [26]. In
our studies there was no statistical difference in secretion
pattern for any of the effectors examined.
Salmonella Targets Non-Phagocytic Lymphocytes
We were surprised to detect secretion of SteA-Bla to
splenic B (CD3- and CD19þ) and T cells (CD3þ and CD4þ or
CD8þ). This is not a consequence of auto-ﬂuorescence for
several reasons. No blue CCF2-AM ﬂuorescence was observed
in B and T cells from mice infected with wild type Salmonella
(not expressing a Bla fusion). Additionally, dead cells that can
exhibit auto-ﬂuorescence were eliminated from analysis using
propidium iodide staining to set live cell gates and
furthermore live cells were selected by their ability to retain
CCF2-AM. Finally, intact Salmonella were observed within
Figure 4. GR-1þ/CD11bþ Cells Consist of Neutrophils and Monocytes
FACS analysis was performed on spleen cells from uninfected C57BL/6 mice or mice infected with 14028 for 2 days (A). The level of GR-1 and CD11b in
total viable spleen cells is shown in the density plots on the left. GR-1þ/CD11bþcells (R1 gate) were analyzed for CD11c and GR-1 expression levels in
the density plots to the right. The level of F4/80 expression for ungated cells (all analyzed cells), R2 and R3 gated cells are shown in the histograms (B).
GR-1 Hi/CD11c Lo (R2) cells and GR-1 Int/CD11c Hi (R3) cells from infected mice were FACS sorted, then cytospun onto slides, and stained with Wright-
Giemsa stain and visualized by microscopy (C). 300 cells from Wright-Giemsa stained slides were analyzed and the percentage of neutrophils and
monocytes was determined. The percentage of total intracellular Salmonella in GR-1þ/CD11bþcells was estimated (D). GR-1þ/CD11bþcells (R1), GR-1 Hi
/ CD11c Lo (R2), GR-1 Int / CD11c Hi (R3) populations were FACS sorted, lysed, then plated on LB to determine the number of intracellular CFU. The
percentage of total recovered CFU was then calculated for each FACS sorted population (see Materials and Methods). The graph shows the average
percentage total recovered CFU present in each FACS sorted population from three mice and the error bars represent one standard error of the mean.
doi:10.1371/journal.ppat.0030196.g004
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Targets of Salmonella Type III Secretionpuriﬁed B and T cells. As these are not professional
phagocytic cells our ﬁrst hypothesis was that SPI-1 secreted
effectors were stimulating engulfment of the bacteria.
However, the percentage of each targeted cell type was
unchanged when FACS analysis was carried out with a SPI-1
mutant suggesting that this was not true. Furthermore, using
competitive index as a sensitive way of gauging virulence,
there was no statistical difference in colonization between the
wild type Salmonella and a SPI-1 mutant (Figure S1C).
By targeting B and T cells Salmonella may inﬂuence the
development of an adaptive immune response. In fact,
infection of B and T cells may account for the course of
infection of typhoid fever in man. In typhoid fever, Salmonella
spreads from primary sites of infection to the bone marrow as
well as to other sites [36]. B cells that have been primed by
exposure to antigen return to the bone marrow to become
blast cells and produce antibody but may be carrying
Salmonella to the bone marrow as cargo. This may explain
why Salmonella is a common cause of osteomyelitis.
Salmonella Is Not Found in Mature Splenic Macrophages
Salmonella was observed within splenic monocytes but not
mature macrophages 48 hours following i.p. infection.
Monocytes are immature macrophages that are morpholog-
ically distinct from mature macrophages based on Wright-
Giemsa staining because they lack ingested material that form
tingible bodies typical of mature histiocytes. In addition,
monocytes express intermediate to high levels of both GR-1
and CD11b whereas macrophages do not (our unpublished
observation; [33–35]). Macrophages were detected among the
splenic cells in our studies and could be infected once the
cells were isolated (Figure S3). Thus the result is puzzling
given the fact that macrophages are professional phagocytes
and considered one of the hallmarks of the innate immune
response to infection. One possibility is that monocytes are
more phagocytic than mature macrophages. In fact a
previous study concluded that Salmonella targets a speciﬁc
subset of highly phagocytic macrophages [18]. Another
possible explanation is that macrophages are being killed by
Salmonella shortly after infection. This explanation would also
explain the decrease of mature macrophages in the spleen by
day 2 of infection (Table 1). Interestingly, Rydstrom and Wick
found that splenic monocytes kill Salmonella more efﬁciently
than neutrophils [22]. Thus the lack of Salmonella in mature
macrophages may result from killing by the precursor cell.
However this is difﬁcult to reconcile with the fact that
Salmonella resides in macrophages at later times of infection
[21] and that the rate of Salmonella killing in vivo is very low
[37,38]. Richter-Dalfors et al found that Salmonella resides
almost exclusively in liver macrophages 5 days post oral
inoculation [21] thus it is possible that mature macrophages
may simply leave the spleen for other sites.
Expression of Cell Surface Proteins Changes on Infection
Pathogen associated molecular patterns are detected by the
host’s innate immune system and result in an immediate
response to the infecting organism. The consequence of this
is up-regulation of cytokines, chemokines, their receptors,
Figure 5. Microscopic Analysis Reveals That FACS Sorted Blue Spleen Cells Contain Intracellular Red-Fluorescent Salmonella
Mice were infected as described in Figure 2. Spleen cell suspensions were prepared then loaded with CCF2-AM to detect secretion (shown in blue).
FACS sorted secretion positive cells (blue cells) were then stained with a DNA stain, DRAQ5 (shown in green), to visualize nuclei. Images were taken at
603 magnification and a single cell is shown in each horizontal row. Red reference bars represent 2 lm.
doi:10.1371/journal.ppat.0030196.g005
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Targets of Salmonella Type III Secretionand adhesion molecules. Classically, speciﬁc cell surface
proteins have been used to distinguish cell types. The
drawback of relying on the same cell surface proteins in
uninfected and infected hosts is evident in Table 1 and from
our other results. This study has the advantage of using two
different approaches to distinguish cell types; by ﬂuorescent
antibody staining to a variety of cell surface proteins followed
by FACS analysis and veriﬁcation by traditional cytological
differentiation after cell sorting. From these two approaches
it is clear that cells express a different spectrum of surface
proteins after infection than in an uninfected mouse
including those that are commonly used to distinguish cell
type. As one example, cell markers that were thought to be
unique to speciﬁc classes of cells such as F4/80 (for macro-
phages) were found on CD11bþ/GR-1þ neutrophils and
monocytes.
Salmonella Survives and Replicates within Neutrophils
The current model for Salmonella systemic infection is that
Salmonella reside and replicate within macrophages. However,
Dunlap et al. found that most Salmonella are within
neutrophils 24 hours after i.v. inoculation [20]. Rydstrom
and Wick also found Salmonella within neutrophils in the
Peyer’s patches and mesenteric lymph nodes 4 days post oral
inoculation [22]. Yet the role of neutrophils in controlling
Salmonella infection is still controversial. One approach to
assess their role in vivo is to deplete neutrophils using speciﬁc
antibodies and then compare course of infection to an
untreated mouse [39–42]. However, depletion studies based
on anti-GR-1 deplete not only neutrophils but also mono-
cytes, consequently it is difﬁcult to assess the role of
neutrophils [22,35,43]. In vitro, neutrophils kill Salmonella
only in the ﬁrst two hours followed by intracellular bacterial
replication [44–46] precisely the same pattern as observed for
primary macrophages [47–50].
Neutrophils are thought to be a dead end for an intra-
cellular pathogen because they are short-lived and highly
microbicidal. They kill bacteria by both oxidative mecha-
nisms (NADPH oxidase and inducible nitric oxide synthetase)
and non-oxidative mechanisms (defensins to depolarize the
bacterial membrane, neutrophil elastase to destroy compo-
nents of the type III secretion system, and a protein net to
capture and destroy bacteria) [51–54]. However, our data
indicates that Salmonella not only resides within neutrophils it
also replicates within these cells. Our ﬁndings challenge the
current paradigm that Salmonella evades neutrophil killing in
vivo by hiding within macrophages. Rather Salmonella actively
targets neutrophils with type III secretion and subverts them
to promote an intracellular niche.
Materials and Methods
Bacterial strains and cell culture. ATCC S. typhimurium 14028 was
the parental strain used in all assays. LB media supplemented with
antibiotics was used unless otherwise stated. Antibiotics were used at
the following concentrations: kanamycin 60 lg/ml, carbenicillin 100
lg/ml. 14028 derivatives and plasmids used in this study are listed in
Table S2. J774s and HeLa cells were obtained from ATCC and grown
in DMEM supplemented with 10% FBS. HeLa cells and J774s were
infected using SPI-1 TTSS and SPI-2 TTSS conditions, respectively, as
previously described [15]. For SPI-1 inducing conditions log phase
cultures were prepared by sub-culturing overnight cultures 1:33 then
growing for three hours with aeration. These cultures were then
washed and diluted before infecting HeLa cells at a MOI of 50. For
SPI-2 inducing conditions, overnight cultures were washed with PBS
then diluted and added to J774s at an MOI of 250. Gentamicin was
added to culture medium as previously described [15] to kill
extracellular bacteria. To prepare samples for FACS analysis, infected
HeLa cells were trypsonized, and infected J774 cells were scraped to
prepare cell suspensions, then 10
7 cells/ml were loaded with .125X
solution of CCF2-AM (Invitrogen) for 2 hours at room temperature
following the manufacturer’s recommendations. To prepare samples
of J774 or HeLa cells for microscopy, cells were seeded in Lab-Tek II
chamber coverglass slides (Nalge Nunc International), infected, and
then 10
7 adherent cells were loaded with 1 ml of 1X CCF2-AM
solution for 2 hours at room temperature.
Generation of effector-Bla fusions and protein expression analysis.
The mini-Tn5-bla transposon was created by replacing the cyaA’ gene
in mini-Tn5-cycler [15] with codons 70–792 of the ß-lactamase gene
from pBluescriptSK. This transposon was then used as a template for
PCR using primers with extensions speciﬁc for the target effector.
PCR products were then used to transform 14028 using the k-red
PCR based recombination technique [55] (See Table S3 for a list of
primers used). Constructs were conﬁrmed by PCR and by sequencing
the PCR products. Each fusion was then transduced into WT 14028,
MJW1301 (ssak::cat) and MJW1835 (invA::cat) backgrounds using P22
phage as previously described [56].
Preparation of spleen cells. All mouse studies were approved by the
Oregon Health and Science University institutional animal care and
use committee (animal protocol #A085). C57BL/6 mice were
inoculated via i.p. injection with ;2 3 10
5 CFU of the desired S.
typhimurium strain. For microscopy, mice were infected with 14028
derivatives carrying plasmid pWKS30-Tomato. Tomato ﬂuorescent
Figure 6. CD3þ and CD19þ Cells Contain Salmonella
Blue cells that are CD3þ or CD19þ were FACS sorted and visualized for the presence of intracellular red-fluorescent Salmonella using fluorescence
microscopy. Experiments were performed as described in Figure 5 and red reference bars represent 2 lm.
doi:10.1371/journal.ppat.0030196.g006
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Targets of Salmonella Type III Secretionprotein was obtained from the Tsien laboratory [32]. pWKS30-
Tomato was generated by cloning a Shine-Dalgarno sequence and the
ﬁrst half of the tdTomato ﬂuorescent protein into pWKS30. After 2
days of infection, spleens were removed and homogenized using
sterile glass slides. The spleen cell suspensions were then digested
with collagenase 0.5 mg/ml and DNAse 50 lg/ml in RPMI at 37 8C for
25 minutes. Red blood cells in the spleen cell suspensions were lysed
by incubation in a hypotonic red blood cell lysis buffer on ice for 5
minutes. Debris and clumps were removed by straining though a 70-
lm cell strainer (BD Falcon). The procedure described above for
cultured cells was used to load CCF2-AM. To prepare samples for
microscopy, FACS sorted spleen cells were stained with DRAQ5
(Alexis Biochemicals) at a 1:1000 dilution then seeded in Lab-Tek II
chamber coverglass slides (Nalge Nunc International).
FACS analysis and sorting. To prepare samples for FACS cells
loaded with CCF2-AM as described above were ﬁrst treated with Fc
receptor blocking antibodies (see Table S4 for a list of anti-bodies
used) for 15 minutes at 4 8C, followed by staining with ﬂuorescently
conjugated antibodies at 4 8C for 15 minutes. FACS analysis was
performed using an LSRII (Becton Dickinson) FACS analysis machine
equipped with 488, 633, and 405-nm lasers. Four cell-surface markers
could be simultaneously analyzed along with CCF2-AM ﬂuorescence.
Cells were simultaneously stained for four lymphoid speciﬁc markers
or four myeloid speciﬁc markers. The lymphoid speciﬁc markers that
were analyzed are: CD3, CD4, CD8, and CD19. Myeloid speciﬁc
markers were: CD11c, CD11b, GR-1, and F4/80 (Table S4). Appro-
priate isotype control antibodies were used to determine the levels of
background staining. Parallel samples were stained with propidium
iodide to determine the settings for a live cell gate based on light
scatter properties. FlowJo (Tree Star) software was used to analyze the
FACS data.
FACS sorting was performed using a FACSVantage SE (Becton
Dickinson), with the Digital Vantage option, using the 633, 488 nm,
and 405 nm lasers. Spleen cells from infected mice were prepared as
described above. Then the cells were stained with antibodies speciﬁc
myeloid cell surface antigens (CD11c, CD11b, GR-1, and F4/80) or
loaded with CCF2-AM and stained with antibodies speciﬁc for B and
T cell antigens (CD19, CD3). Cells of the desired populations, as
described in the results section, were sorted into RPMI media
containing gentamicin 100 lg/ml. Reanalysis of sorted cells deter-
mined that .99% purity was achieved.
Cell pathology. Spleen samples from infected mice were prepared
for Wright-Giemsa staining as follows. 1 ml of RPMI containing ;13
10
4–5 3 10
4 cells were cytospun onto slides using a Cytospin 2
(Shandon) at 1,500 RPM for 5 minutes. After air-dry ﬁxing, samples
were processed for Wright-Giemsa staining [57,58]. Samples were
visualized by microscopy and scored for differentials, counting at
least 300 cells per sample. Microscopy pictures of Wright-Giemsa
stained slides were captured at 1003 magniﬁcation using a Micro-
phot-FX (Nikon) microscope equipped with a Magnaﬁre (Optronics)
camera and using Magnaﬁre (Optronics) software.
Microscopy on infected cells. Cells prepared as described above
were visualized using 603 or 403 oil-immersion lenses along with
emission ﬁlter sets for blue (457 nm) and green (528 nm) ﬂuorescence
by CCF2-AM, Tomato ﬂuorescent protein (617 nm), and DRAQ5 (685
nm). A UV laser with a DAPI excitation ﬁlter was used for CCF2-AM
excitation, a 568 nm laser was used for Tomato excitation, and a 647-
nm laser was used for DRAQ5 excitation. z-sections (0.2 lm) were
captured at a resolution of 1,024 by 1,024 pixels. Images were
acquired by Aurelie Snyder of the OHSU-MMI Research Core Facility
(http://www.ohsu.edu/core/) with an Applied Precision DeltaVision
image restoration system. This includes an API chassis with a
precision motorized XYZ stage, a Nikon TE200 inverted ﬂuorescence
microscope with standard ﬁlter sets, halogen illumination with an
API light homogenizer, a CH350L camera (500 kHz, 12-bit, 2 Mp, KAF
1400 GL, 1,317 3 1,035, liquid cooled), and DeltaVision software.
Deconvolution using the iterative constrained algorithm of Sedat and
Agard, and additional image processing were performed using
Softworx Explorer Suite (Applied Precision) image processing
software.
Determining percentage of intracellular bacteria in various cell
populations. To determine intracellular CFUs, non-speciﬁcally sorted
spleen cells (viable cell gate based on light scatter properties) or
speciﬁcally sorted spleen cell populations were incubated in RPMI
containing gentamicin 100 lg/ml ;2 hours. The cells were then lysed
in PBS with 1% Triton X-100 (Sigma) and serial dilutions were plated
on LB agar to determine the number of CFU of S. typhimurium present
per 10
5 host cells. To determine the percentage of intracellular
bacteria present in different cell populations, the following formula
was used: [(CFU/10
5 speciﬁcally sorted spleen cells) 3 F1] / [(CFU/10
5
nonspeciﬁcally sorted spleen cells)3F2] 3100. Where F1 and F2 are
the fractions that a speciﬁcally sorted cell population or a non-
speciﬁcally sorted cell population, respectively, represent out of the
total spleen cell population. For example, if the CD11bþ/GR-1 Hi/
CD11c Lo (neutrophils) cell population represented 6% (F1¼0.06) of
the total spleen cells and contained ;40 CFU / 10
5 cells and if in the
same mouse, the non-speciﬁcally sorted spleen cells contain ;10 CFU
/1 0
5 cells and represent 33.4% (F2 ¼ 0.334) of the total spleen cells.
Then using the formula above we would calculate: (40 3 0.06) / (10 3
0.334) 3 100 ¼ 72%.
Supporting Information
Figure S1. Analysis of Mice Infected i.p. with an Inoculum of 2 3 10
5
The number of bacteria present in the spleen at 24-h intervals
following S. typhimurium 14028 infection was determined using at least
three mice per time point (A). At 72 hours only nine of 14 mice
survived and at 96 h only three out of seven mice survived. The graph
shows the log of the number of bacteria present 6 one standard error
of the mean. Mouse survival assays comparing WT 14028, invA::cat and
ssaK::cat were performed using ﬁve mice per group. (B). The
percentage of mice surviving at 24-h intervals following inoculation
is shown. 4/5 mice infected with ssaK::cat survived for 28 days (not
shown). Competitive infections were performed mixing WT 14028,
invA::cat or ssaK::cat with MA6054 at a 1:1 ratio and by mixing ssaK::cat
with invA::cat expressed in the same background as MA6054 at a 1:1
ratio (C). 2 days following infection, the number of both strains of
bacteria present in the spleen was determined and used to calculate
the competitive index (CI) (see Protocol S1). The graph shows the
mean CI from ﬁve mice 6 one standard error of the mean. The *
indicates that the Student’s t-test returned a value of p , 0.0001 when
compared to the control infection.
Found at doi:10.1371/journal.ppat.0030196.sg001 (34 KB PDF).
Figure S2. CCF2-AM Is Only Efﬁciently Loaded into Live Cells
Spleen cell suspensions were prepared from infected mice and loaded
with CCF2-AM. Dead cells (left panel) and live cells (right panel) were
gated based on light scatter properties then analyzed for green CCF2-
AM ﬂuorescence. The histograms show the number of cells on the y-
axis and the relative green ﬂuorescence intensity, indicating CCF2-
AM loading, on the x-axis.
Found at doi:10.1371/journal.ppat.0030196.sg002 (17 KB PDF).
Figure S3. CCF2-AM Cleavage Detected in All Spleen Cell Types
Spleen cell suspensions were infected with the SteA-Bla strain for 1
hour using SPI-1 inducing conditions. Spleen cells were loaded with
CCF2-AM, stained with antibodies, then analyzed by FACS.
Found at doi:10.1371/journal.ppat.0030196.sg003 (25 KB PDF).
Figure S4. CD115 Expression on GR-1þ/CD11bþ Neutrophils and
Monocytes
FACS analysis was performed on spleen cells from mice infected with
14028 for 2 days. The level of GR-1 and CD11b in total viable spleen
cells is shown in the density plots on the left (A). GR-1þ/CD11bþcells
(R1 gate) were analyzed for CD11c and GR-1 expression levels in the
density plots to the right. The level of CD115 expression for ungated
cells (all analyzed cells), R2 (neutrophils), and R3 (monocytes) gated
cells are shown in the histograms (B).
Found at doi:10.1371/journal.ppat.0030196.sg004 (32 KB PDF).
Protocol S1. Supplemental Methods for Mouse Infection Studies
Found at doi:10.1371/journal.ppat.0030196.sd001 (23 KB DOC).
Table S1. Percentage of Blue Spleen Cells Represented by Speciﬁc
Cell Types from Mice Infected with Salmonella Expressing the SteA-
Bla Fusion in an invA::cat Background
Found at doi:10.1371/journal.ppat.0030196.st001 (21 KB DOC).
Table S2. Strains and Plasmids Used in This Study
Found at doi:10.1371/journal.ppat.0030196.st002 (41 KB DOC).
Table S3. Primers Used in This Study
Found at doi:10.1371/journal.ppat.0030196.st003 (32 KB DOC).
Table S4. Antibodies Used for FACS Analysis
Found at doi:10.13711/journal.ppat.0030196.st004 (29 KB DOC).
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Targets of Salmonella Type III SecretionVideo S1. 3-D Rotation of a Blue Spleen Cell Containing Red
Fluorescent Salmonella
Found at doi:10.1371/journal.ppat.0030196.sv001 (475 KB MOV).
Video S2. Example of a Sorted Secretion Positive Cell with a
Polymorphonuclear Appearance That Contains Red Fluorescent
Salmonella
3-D rotation of the cell shown in the top row of Figure 4.
Found at doi:10.1371/journal.ppat.0030196.sv002 (2.6 MB MOV).
Video S3. Example of a Sorted Secretion Positive Cell with a
Polymorphonuclear Appearance That Contains Red Fluorescent
Salmonella
3-D rotation of the cell shown in the second row (from the top) of
Figure 4.
Found at doi:10.1371/journal.ppat.0030196.sv003 (2.3 MB MOV).
Video S4. Example of a Sorted Secretion Positive Cell with a
Polymorphonuclear Appearance That Contains Red Fluorescent
Salmonella
3-D rotation of the cell shown in the third row (from the top) of
Figure 4.
Found at doi:10.1371/journal.ppat.0030196.sv004 (2.3 MB MOV).
Video S5. Example of a Sorted Secretion Positive Cell with a
Polymorphonuclear Appearance That Contains Red Fluorescent
Salmonella
3-D rotation of the cell shown in the bottom row of Figure 4.
Found at doi:10.1371/journal.ppat.0030196.sv005 (2.4 MB MOV).
Accession Numbers
PubMed nucleotide or protein accession numbers are SipA: Nucleo-
tide accession number AF458099, SptP: Nucleotide accession number
U63293, SlrP: Nucleotide accession number AF127079, SseJ: Nucleo-
tide accession number AF294582, SteA (STM1583): Protein accession
number AAL20501, SteC (STM1698): Protein accession number
AAL20615.
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